TY  - GEN
AU  - Roth,Arnaud D
AU  - Delorenzi,Mauro
AU  - Tejpar,Sabine
AU  - Yan,Pu
AU  - Klingbiel,Dirk
AU  - Fiocca,Roberto
AU  - d'Ario,Giovanni
AU  - Cisar,Laura
AU  - Labianca,Roberto
AU  - Cunningham,David
AU  - Nordlinger,Bernard
AU  - Bosman,Fred
AU  - Van Cutsem,Eric
TI  - Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer
SN  - 1460-2105
PY  - 2013///0111
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Camptothecin
KW  - administration & dosage
KW  - Chemotherapy, Adjuvant
KW  - Chromosomes, Human, Pair 18
KW  - Colonic Neoplasms
KW  - drug therapy
KW  - Drug Administration Schedule
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Immunohistochemistry
KW  - Irinotecan
KW  - Kaplan-Meier Estimate
KW  - Leucovorin
KW  - Loss of Heterozygosity
KW  - Male
KW  - Microsatellite Instability
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Mutation
KW  - Neoplasm Staging
KW  - Predictive Value of Tests
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Proto-Oncogene Proteins
KW  - Proto-Oncogene Proteins B-raf
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Research Design
KW  - Smad4 Protein
KW  - metabolism
KW  - ras Proteins
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/jnci/djs427
ER  -